Ruti Aga and the Old Prescription Pad: The Six-Year Ban Hangs on Paper, Not on Steroids

The clinic printed on the paper had a name you could read without squinting. The problem was that the clinic did not exist. The prescription placed before the Athletics Integrity Unit was written on an "old prescription pad" lifted from a former workplace, signed by a member of Ruti Aga's family who held no medical registration. The clinic whose name sat at the top of the pad told investigators plainly that the pad was not theirs and that the man had never been registered there.

Three separate verifications, three failures: no clinic, no doctor, no valid pad. Any one of the three holding up and this case might have collapsed into a conversation about a knee injection and its timing.

I keep returning to that old prescription pad, because access is never just a credential. A lanyard tells you who is inside the stadium; a prescription pad tells you who has a real doctor and who has only paper.

Aga is a thirty-two-year-old Ethiopian marathoner. She won Tokyo in 2026 and has three second-place finishes at World Marathon Majors. Her personal best is usually listed around 2:18:34 from Berlin 2026 — that number is not in the AIU statement, it comes from external records, so read it as background rather than proof. In March she won a half marathon in China. Her in-competition sample from that race returned methylprednisolone. She had been provisionally suspended since 10 September, and on Thursday the AIU issued its statement: two years for presence, four for tampering, six in total, counted from 10 September.

I watched that 2026 Tokyo race at four in the morning on a stream, and what stayed with me was her rhythm — no surges, no gamble on any single kilometre. I did not know then that I would one day write her name down not because of a finish-line photograph but because of a form.

The reports called methylprednisolone a "prohibited steroid." That is technically wrong, and the error files the whole case in the wrong drawer.

Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 on the WADA Prohibited List, and it is prohibited in-competition only — and only when it enters the body by injection, orally, or rectally. Which means the knee injection described here is entirely legal out of competition. It becomes a violation only if residues are present on race day.

So the case was never about whether she took a steroid. It was about two questions: what was the route, and how many days before the race was the last injection. A road race's testing window opens at 23:59 the night before. An injection given days earlier can still be caught inside it. Intra-articular methylprednisolone for knee synovitis is ordinary sports medicine for distance runners. That fact was useful to the defence, and it is precisely why the forged paperwork became fatal.

Had the paperwork been real, the defence would have been built on real paperwork. The forged prescription closed the one route that might have stayed open: medical necessity, route of administration, and a technical account of timing. The panel was not being asked whether the knee hurt — that was accepted. It was being asked whether the document proving treatment was genuine, and the document was not. Forgery does not require a real treatment anyway; it requires a real problem, which here was a knee, and behind the knee a system with no credentialed team physician in it.

Read the arithmetic. Two years for presence sits close to the band where intent is not proven. Four years for tampering is the Code's standard sanction. Together they tell us the panel declined the no-significant-fault mitigation that could have cut the presence period further. There is a quiet paradox: forged documents are themselves evidence of concealment, yet they did not escalate the presence charge. The panel weighed the two on separate scales.

Six years at thirty-two is not six years. Count from 10 September and the return lands near thirty-eight. Ethiopia's women's marathon is deep enough that a 2:18 performer is not automatically selectable. On paper the ban is six years; in career terms it is a lifetime.

China's label-race circuit deserves separate attention here. Large appearance fees, deep East African elite fields and AIU testing are converging on the same races. Between Majors, that circuit is a low-race-count, high-income model for marathoners. It is also now the most scrutinised tier in the sport, and the appearance-fee economy is colliding with the testing economy on the same start line.

What is shifting fastest is not detection technology but document verification. The enforcement frontier has moved from "what was in the sample" to "does the piece of paper exist." One phone call, one email, one registration number — three checks, and the story changes.

The instinctive reaction is that six years is excessive, because methylprednisolone has no proven endurance benefit. That reaction is half right and wholly wrong. The weight of this sanction falls on the paper, not on the drug. No panel hands out six years for a glucocorticoid injection; it hands out six years to the man who walks into an investigation carrying a forged prescription. Calling this a doping case is easy and inaccurate.

The family-member doctor is an aggravating fact, not a mitigating one. When the person writing the prescription is not a registered physician, it becomes clear that no legitimate medical structure existed around the athlete — no team doctor, no therapeutic use exemption pathway, nobody who could say how many days must separate an injection from a race. That is the real blind spot, and it belongs to a training cluster rather than to one woman.

When the media calls this a steroid case, it gets called fast, brave reporting. They called the column brave; I thought it was just the truth arriving late — and half of it. Because the word "steroid" turns this into a story about anabolic cheating, and then nobody asks why the athlete had no registered doctor. The day that question gets asked, this stops being one person's mistake and becomes a report on a system.

Six weeks of silence, then one microphone — my own career sentence stands here inverted: six years of silence, and no microphone at all. A comeback at thirty-eight is not closed to an Ethiopian marathoner. Being available and being selectable are different things.

The cases coming over the next two seasons will not be decided by the fastest question, which is what was in the sample. They will be decided by who picked up the phone number printed on the prescription. And when the answer is nobody, the count starts with the drug and ends with the paper, exactly as it did here. The question left standing is simple: next time a runner needs a knee injected, will the man beside her be a registered doctor, or a relative holding an old pad?